India to Germany: Potassium Export Trade Route

The India to Germany Potassium corridor is one of India's established pharmaceutical export routes, with 89 shipments documented worth a combined $19.9M USD. The route is dominated by ZYDUS TAKEDA HEALTHCARE PRIVATE LIMITED, which alone accounts for roughly 60% of all export value, reflecting the consolidated nature of India's potassium manufacturing sector.

Across 10 active suppliers, the average shipment value stands at $224.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during October–December, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 33.1%, placing it at rank #18 among India's top potassium export destinations globally.

On the import side, key buyers of Indian potassium in Germany include FIRMA, , TAKEDA GMBH FIRMA, TAKEDA GMBH, FIRMA and 17 others. FIRMA, is the single largest importer with 2 shipments valued at $5.5M USD.

India's potassium exports to Germany are driven primarily by a handful of large-scale manufacturers. ZYDUS TAKEDA HEALTHCARE PRIVATE LIMITED with 7 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 10 active exporters signals a competitive but concentrated market — buyers in Germany benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ZYDUS TAKEDA HEALTHCARE PRIVATE LIMITED, ZYDUS TAKEDA HEALTHCARE PRIVATE LIMITED , AUROBINDO PHARMA LTD — together account for 92% of total trade value on this route. The average shipment value of $224.1K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as azilsartan medoxomil potassium (tak-491) and azilsartan medoxomil potassium tak-491, suggesting that buyers in Germany tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, FIRMA, is the largest importer with 2 shipments worth $5.5M USD — representing 28% of all potassium imports from India on this route. A total of 20 buyers are active on this corridor.